Towards Healthcare

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Clene’s new clinical data claims to improve brain energy metabolism
30 September 2025

Clene’s new clinical data claims to improve brain energy metabolism

Image Credit: Symbiosys Capital Management Announcement The Clene Inc., and its fully owned subsidiary Clene Nanomedicine Inc., a leading clinical stage biopharmaceutical company that targets mitochondrial health improvement and provides a safe space for neuronal function, has unveiled its prese...

Femasys to strengthen its footprint in Europe by partnering with Kebomed
30 September 2025

Femasys to strengthen its footprint in Europe by partnering with Kebomed

Image Credit: Femasys Inc. Announcement Femasys Inc., a known biomedical innovator making accessible fertility and non-surgical permanent birth control, and has been cost-effective to the women's community globally, has entered a partnership with Kebomed, a popular European medical device and eq...

The UK intends to build a regulatory wall with AI rules for the healthcare sector
30 September 2025

The UK intends to build a regulatory wall with AI rules for the healthcare sector

Image Credit: National Health Executive Announcement The UK is now focusing on regulations for artificial intelligence (AI) in healthcare by appointing a national commission to support the country in attracting investors to invest largely and reliably in health-tech and contribute to excellence ...

Docotela, introduce medical consultations online
29 September 2025

Docotela, introduce medical consultations online

Image Credit: MedTour Announcement Docotela, a startup company in South Africa, introduced a South African telehealth platform docotela. Docotela means ‘doctor’ in the Zulu language, building a bridge for providers and patients to meet online. The platform is putting efforts to make ...

Moderna’s new vaccine facility fuels the UK pharmaceutical industry
29 September 2025

Moderna’s new vaccine facility fuels the UK pharmaceutical industry

Image Credit: Pharmaceutical Technology Announcement Moderna, the leading vaccine maker, has inaugurated the new manufacturing space in Oxfordshire in an acceleration of the pharmaceutical company after another crucial firm listed or halted the plans regarding UK investment this year. The compan...

Sandoz’s iron sucrose injection, a new relief to US patients
29 September 2025

Sandoz’s iron sucrose injection, a new relief to US patients

Image Credit: India Pharma Outlook Announcement Sandoz, a known leader in producing affordable medicines, has entered the US with its generic iron sucrose injection with the approval of the US Food and Drug Administration (FDA). The product is marketized and also ready for delivery and order thr...

PepGen confirmed its proposed public offering
29 September 2025

PepGen confirmed its proposed public offering

Image Credit: Oxford University Innovation Announcement Pepgen Inc., a leading clinical-level biotechnology company advancing the next generation future of oligonucleotide therapies with a motive of transitioning the treatment of neurological disease and extreme neuromuscular, declared that they...

Agility’s oncology-based technologies and services to expand in the US
26 September 2025

Agility’s oncology-based technologies and services to expand in the US

Image Credit: Ricoh USA Announcement Agility, a known provider and manufacturer of medical device solutions to the US healthcare industry, has extended its advanced oncology offering to hospitals and physicians, with the highest value and availability to focal therapy services for treating and d...

Sophia and myriad partnered to introduce innovation in liquid biopsy
26 September 2025

Sophia and myriad partnered to introduce innovation in liquid biopsy

Image Credit: Cinical Lab Products Announcement Myriad Genetics, a known face of precision medicine and molecular diagnostic testing, and Sophia Genetics, a leading AI technology company revolutionizing precision medicine, have entered a smart partnership to offer and develop pharmaceutical comp...

Ncardia’s ncyte to promote non-human primate cardiomyocytes
26 September 2025

Ncardia’s ncyte to promote non-human primate cardiomyocytes

Image Credit: Ncardia Announcement Ncardia, a known face in stem cell-related solutions for drug safety assessment and discovery, launched ncyte NHP-C vCardiomyocytes, the first ever available ventricular cardiomyocytes at the commercial stage. It is derived from the induced pluripotent stem cel...